Statistics for Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1

Total visits

views
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1 107

Total visits per month

views
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0

File Visits

views
nihms-1628720.pdf 185

Top country views

views
United States 72
Belgium 10
Canada 2
Czechia 2
China 1
Germany 1
France 1
Italy 1
Mexico 1
Malaysia 1
Portugal 1
Sweden 1

Top city views

views
Wilmington 36
Fairfield 10
Houston 6
Moerbeke 5
Cambridge 3
Ann Arbor 2
Antwerpen 2
Molenbeek 2
San Francisco 2
Toronto 2
Beijing 1
Bloomfield 1
Chicago 1
Indianapolis 1
Kansas City 1
Kiez 1
Los Angeles 1
Mechelen 1
Mexico 1
Nanterre 1
Praha 1
Seattle 1
Segrate 1
Seremban 1
Slapanice 1
Stockholm 1